相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice
Kate Smith-Jackson et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Calpain Inhibition Restores Autophagy and Prevents Mitochondrial Fragmentation in a Human iPSC Model of Diabetic Endotheliopathy
Sang-Bing Ong et al.
STEM CELL REPORTS (2019)
VEGFR2 activation mediates the pro-angiogenic activity of BMP4
Sara Rezzola et al.
ANGIOGENESIS (2019)
Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database
Mamta Puraswani et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome
Wei-yi Guo et al.
PEDIATRIC NEPHROLOGY (2019)
Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment
Rupesh Raina et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2019)
Cytokines trigger disruption of endothelium barrier function and p38 MAP kinase activation in BMPR2-silenced human lung microvascular endothelial cells
Birger Tielemans et al.
PULMONARY CIRCULATION (2019)
Factor H Autoantibodies and Membranous Nephropathy
Claudia Seikrit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Induced pluripotent stem cell technology: a decade of progress
Yanhong Shi et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome
Di Song et al.
PEDIATRIC NEPHROLOGY (2017)
BMP4 uses several different effector pathways to regulate proliferation and differentiation in the epithelial and mesenchymal tissue compartments of the developing mouse ureter
Tamrat M. Mamo et al.
HUMAN MOLECULAR GENETICS (2017)
The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells
Isabelle Corre et al.
ONCOTARGET (2017)
Huntington's Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits
Ryan G. Lim et al.
CELL REPORTS (2017)
Modeling cadmium-induced endothelial toxicity using human pluripotent stem cell-derived endothelial cells
Ling Tang et al.
SCIENTIFIC REPORTS (2017)
Induced Pluripotent Stem Cell Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity
Silin Sa et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers
Mingxia Gu et al.
CELL STEM CELL (2017)
Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation
Yoshiyasu Ueda et al.
BLOOD (2017)
Transcriptional Analysis of Intravenous Immunoglobulin Resistance in Kawasaki Disease Using an Induced Pluripotent Stem Cell Disease Model
Kazuyuki Ikeda et al.
CIRCULATION JOURNAL (2017)
Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31)
Panida Lertkiatmongkol et al.
CURRENT OPINION IN HEMATOLOGY (2016)
Anti-complement-factor H-associated glomerulopathies
Marie-Agnes Dragon Durey et al.
NATURE REVIEWS NEPHROLOGY (2016)
The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling
Emilie Barruet et al.
STEM CELL RESEARCH & THERAPY (2016)
Cellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells
Shuji Hamauchi et al.
PLOS ONE (2016)
Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts
Gen Kuroyanagi et al.
MOLECULAR MEDICINE REPORTS (2015)
Loss of DGKε induces endothelial cell activation and death independently of complement activation
Sarah Bruneau et al.
BLOOD (2015)
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
Aditi Sinha et al.
KIDNEY INTERNATIONAL (2014)
Diagnosis and Treatment of the Hemolytic Uremic Syndrome Disease Spectrum in Developing Regions
Johannes Hofer et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2014)
Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G > A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients
Toshiaki Hitomi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Pdgfra protects against ethanol-induced craniofacial defects in a zebrafish model of FASD
Neil McCarthy et al.
DEVELOPMENT (2013)
VE-Cadherin and Endothelial Adherens Junctions: Active Guardians of Vascular Integrity
Monica Giannotta et al.
DEVELOPMENTAL CELL (2013)
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation
Silvia Rossi et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Inhibition of p38 MAPK Reduces Expression of Vascular Endothelial Growth Factor in Allergic Airway Disease
So Ri Kim et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Overall Neutralization of Complement Factor H by Autoantibodies in the Acute Phase of the Autoimmune Form of Atypical Hemolytic Uremic Syndrome
Caroline Blanc et al.
JOURNAL OF IMMUNOLOGY (2012)
Interaction between smoking and functional polymorphism in the TGFB1 gene is associated with ischaemic heart disease and myocardial infarction in patients with rheumatoid arthritis: a cross-sectional study
Ying Chen et al.
ARTHRITIS RESEARCH & THERAPY (2012)
The Development of Atypical Hemolytic Uremic Syndrome Depends on Complement C5
Elena Goicoechea de Jorge et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Atypical hemolytic uremic syndrome
Chantal Loirat et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
Marina Noris et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
p38 maintains E-cadherin expression by modulating TAK1-NF-κB during epithelial-to-mesenchymal transition
Raffaele Strippoli et al.
JOURNAL OF CELL SCIENCE (2010)
Clinical Features of Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome
Marie-Agnes Dragon-Durey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome
Stefanie Strobel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer
Hae-Young Yong et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
MEDICAL PROGRESS Atypical Hemolytic-Uremic Syndrome
Marina Noris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Complement and the atypical hemolytic uremic syndrome in children
Chantal Loirat et al.
PEDIATRIC NEPHROLOGY (2008)
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
Mihaly Jozsi et al.
BLOOD (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Anti-factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome
Mihaly Jozsi et al.
BLOOD (2007)
Genetics of HUS:: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
Jessica Caprioli et al.
BLOOD (2006)
Hemolytic uremic syndrome
M Noris et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome
MA Dragon-Durey et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The p38 MAP kinase pathway as a therapeutic target in inflammatory disease
J Saklatvala
CURRENT OPINION IN PHARMACOLOGY (2004)
p38 map kinases: Key signalling molecules as therapeutic targets for inflammatory diseases
S Kumar et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
p38 MAP kinase -: a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability
K Issbrücker et al.
FASEB JOURNAL (2002)
分享论文
